Company: MYSEW
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001213900-25-110045
Chunk: 37

Company: Myseum, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 37
---
 Underwriting Agreement, each of the Company’s directors and executive officers entered into “lock-up” agreements
with the Representative that generally prohibit, without the prior written consent of the Representative and subject to certain exceptions,
the sale, transfer or other disposition of securities of the Company until July 17, 2024. Further, pursuant to the terms of the Underwriting
Agreement, the Company agreed for a period of 180-days from the closing date, subject to certain exceptions, not to issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any shares of capital stock of the Company or any securities convertible
or exercisable or exchangeable for shares of capital stock of the Company; (ii) file any registration statement; (iii) complete any offering
of debt securities of the Company, other than entering into a line of credit with a traditional bank, or (iv) enter into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company.

2025

Common Stock Sold for Cash

On January 7, 2025, the Company entered into an
engagement agreement with The Benchmark Company, LLC, as exclusive placement agent (“Benchmark” or the “Placement Agent”),
pursuant to which the Placement Agent agreed to act as placement agent on a reasonable “best efforts” basis in connection
with the Offering. The Company agreed to pay the Placement Agent an aggregate cash fee equal to 7.0% of the gross proceeds from the sale
of securities in the Offering and a non-accountable expense allowance equal to 1.0% of the gross proceeds raised in the Offering. The
Company also agreed to issue the Placement Agent (or its designees) a warrant (the “Placement Agent Warrant”) to
purchase up to 5% of the aggregate number of shares of Common Stock sold in the offering or warrants to purchase up to 60,000 shares of
Common Stock, at an exercise price equal to 100.0% of the offering price per share of Common Stock, or $4.25 per share. The Placement
Agent Warrant is exercisable during the four-and-a-half year period commencing six months after the date of the closing of this Offering.
In addition, the Company agreed to pay the Placement Agent $80,000 for legal expenses and other out-of-pocket expenses.

On January 8, 2025, in connection with the